Potential of Molecular-Driven Stratification for Osteosarcoma Treatment and Prognosis



March 9, 2023

  • Share
  • Oncotarget published this editorial in Volume 14, entitled, “Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis" by researchers from the INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. DOI - https://doi.org/10.18632/oncotarget.28364 Correspondence to - Antonin Marchais - ANTONIN.MARCHAIS@gustaveroussy.fr Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28364 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - multiomics, osteosarcoma, bone sarcoma, stratification About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Cancer ResearchCell ScienceMicrobiologyMolecular Biology

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.